Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis.

Background: This study evaluated the role of HA as a marker of liver fibrosis in patients with hepatitis C on haemodialysis.

Methods: This is a cross-sectional study in which 52 patients were divided into two groups: Group 1: patients with hepatitis C and end-stage renal disease (ESRD) undergoing haemodialysis (n = 23); and Group 2: patients with hepatitis C without ESRD (n = 29). Plasma levels of HA were associated with histological data of the samples obtained by liver biopsy and classified by METAVIR group scoring system.